Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_assertion description "[Hybrids formed by fusion of either human acute lymphoblastic or chronic lymphocytic leukemia cells and the mouse myeloma P3.X63.Ag8/653 have been used to show that the expression of two cell surface antigens, Bp37 and p76, associated with B cell activation and detected by the monoclonal antibodies BB1 and BB2, respectively, segregate with human chromosomes 12 and 19, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_assertion evidence source_evidence_literature NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_assertion SIO_000772 3871395 NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_assertion wasDerivedFrom befree-20140225 NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_assertion wasGeneratedBy ECO_0000203 NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP915716.RA8vJ5A6H-c0vQFEA35Ap5Xm9KQ7MCiaybqMppvo3a5d8130_provenance.